生物制药工艺开发中的机械模型的合格
Till Briskot1, Dominik Hiltmann1, Federico Rischawy1
1Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Riß, 88397 Biberach, Germany.
Journal of pharmaceutical sciences
|December 1, 2024
概括
一个新的框架提供了一种系统的,基于风险的方法,用于资格化生物制药开发中的机械过程模型. 这旨在在行业中标准化模型的使用和决策.
科学领域:
- 生物制药工艺开发 生物制药过程开发
- 计算机建模 计算建模
- 监管科学 监管科学
背景情况:
- 机械过程模型对于生物制药过程设计和控制至关重要.
- 缺乏明确的指导方针阻碍了模型的合格和监管的接受.
- 现有的框架提供部分解决方案,但需要整合.
研究的目的:
- 引入一个系统和基于风险的框架,用于合格的机械过程模型.
- 为生物制药开发中模型适用性评估提供指导.
- 促进共识和协调行业中的建模实践.
主要方法:
- 开发一个新的资格框架,整合已建立的建模准则.
- 该框架应用于两个生物制药案例研究:超过/透过和染色学.
- 基于风险的模型适合决策的评估.
主要成果:
- 通过成功实施案例研究来证明框架的适用性.
- 确定了模型合格的关键要素,包括数据要求和验证方法.
- 为评估模型性能和可靠性提供了一个结构化的方法.
结论:
- 拟议的框架为生物制药开发中的机械模型资格提供了坚实的基础.
- 它促进了对话,并指导建模人员实现标准化,基于风险的资格认证流程.
- 实施可以带来协调的行业实践,并增加对基于模型的决策的信心.
相关概念视频
Mechanistic Models: Overview of Compartment Models
67
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
67
Pharmacokinetic Models: Comparison and Selection Criterion
43
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
43
Pharmacokinetic Models: Overview
587
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
587
Model Approaches for Pharmacokinetic Data: Physiological Models
31
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
31
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
30
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
30
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
58
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
58


